Related Experiment Video
Updated: Jan 20, 2026

Interview: Protein Folding and Studies of Neurodegenerative Diseases
Published on: July 16, 2008
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
Luke McAlary1,2, Steven S Plotkin3,4, Neil R Cashman5
1Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, V6T 1Z1, Canada. lmcalary@phas.ubc.ca.
Neurodegenerative diseases like Alzheimer's and Parkinson's involve protein misfolding and aggregation. New therapies targeting this "proteotoxicity" are in early clinical trials.
Area of Science:
- Neuroscience
- Pathology
- Pharmacology
Background:
- Neurodegenerative diseases, including Alzheimer's and Parkinson's, are common and characterized by protein misfolding and aggregation.
- These misfolded proteins can form toxic oligomers, fibrils, and plaques, leading to cellular dysfunction.
- Proteotoxicity is a central mechanism in the pathophysiology of these debilitating conditions.
Purpose of the Study:
- To summarize the shared pathophysiology of major neurodegenerative diseases.
- To review emerging therapies in early-phase clinical trials that specifically target proteotoxicity.
- To highlight the potential of novel therapeutic strategies for conditions like Alzheimer's and Parkinson's disease.
Main Methods:
- Review of existing literature on neurodegenerative disease pathophysiology.
- Analysis of early-phase clinical trial data for proteotoxicity-targeting therapies.
- Synthesis of information from immunohistochemical studies and genetic screening.
Main Results:
- Protein misfolding and aggregation into toxic species are common hallmarks across various neurodegenerative diseases.
- Several therapeutic approaches are under investigation, including enhancing cellular protein quality control and immunotherapy.
- Early-phase clinical trials are exploring interventions aimed at mitigating proteotoxicity.
Conclusions:
- Proteotoxicity is a unifying pathological feature of common neurodegenerative diseases.
- Targeting protein misfolding and aggregation represents a promising therapeutic avenue.
- Ongoing clinical trials offer hope for new treatments for Alzheimer's, Parkinson's, and related disorders.
Related Concept Videos
Emerging Adulthood
Introduction Cardiac Emergencies
Applications of GIS: Disaster Management and Emergency Response
Sustainable Development
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

